The schedule is subject to change. Because the schedule is provided as public information only, it is not intended to serve as notice to any party.
This page was last updated on September 17, 2021 at 09:45.
The Honorable Roy B. Dalton, Jr.
Hearings Calendar
September 27 to October 1, 2021
Monday | |||||
| Date | Time | Case No. | DE # | Party | Hearing Type |
09/27/2021 No Scheduled Court Activity | |||||
Tuesday | |||||
| Date | Time | Case No. | DE # | Party | Hearing Type |
| 09/28/2021 | 10:00 | 6:21-cv-01287-RBD-DAB | 44 | Merced et al v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01299-RBD-DAB | 16 | Schimming et al v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01300-RBD-DAB | 38 | Pederson v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01301-RBD-DAB | 28 | Becker v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01302-RBD-DAB | 35 | Witt v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01304-RBD-DAB | 48 | Gustin et al v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01305-RBD-DAB | 48 | Dean v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01309-RBD-DAB | 39 | Poitra v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01310-RBD-DAB | 23 | Isaacson v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01312-RBD-DAB | 30 | Giancaspro v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01313-RBD-DAB | 58 | Hurd v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01315-RBD-DAB | 50 | Garland v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01320-RBD-DAB | 37 | Craig v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01327-RBD-DAB | 76 | Colella v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01335-RBD-DAB | 54 | Tonge v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01336-RBD-DAB | 36 | Lally v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01371-RBD-DAB | 31 | Davis v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01374-RBD-DAB | 51 | Burke v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01389-RBD-DAB | 5 | Miller et al v. Novartis Pharmaceuticals Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-cv-01408-RBD-DAB | 19 | Riley v. Novartis Pharmaceutical Corporation | Status Conference |
| 09/28/2021 | 10:00 | 6:21-md-03006-RBD-DAB | 6 | In Re: Tasigna (Nilotinib) Products Liability Litigation | Status Conference |
Wednesday | |||||
| Date | Time | Case No. | DE # | Party | Hearing Type |
09/29/2021 No Scheduled Court Activity | |||||
Thursday | |||||
| Date | Time | Case No. | DE # | Party | Hearing Type |
09/30/2021 No Scheduled Court Activity | |||||
Friday | |||||
| Date | Time | Case No. | DE # | Party | Hearing Type |
10/01/2021 No Scheduled Court Activity | |||||